All companies › LUNG

LUNG · Pulmonx Corp

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys0
Open-market sells14
Research cases0
Last filing2026-09-01

Insider flow: Selling only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-09-01 — Lehman David Aaron · sold 2,224 @ $2.26 2026-09-01 — Lehman David Aaron · sold 3,476 @ $2.26 2026-09-01 — Lehman David Aaron · sold 3,807 @ $2.26 2026-09-01 — Lehman David Aaron · sold 4,827 @ $2.26 2026-09-01 — Rose Geoffrey Beran · sold 1,530 @ $2.26 2026-09-01 — Rose Geoffrey Beran · sold 1,746 @ $2.26 2026-09-01 — Rose Geoffrey Beran · sold 2,213 @ $2.26 2026-09-01 — Rose Geoffrey Beran · sold 2,390 @ $2.26 2026-09-01 — French Glendon E. III · sold 37,784 @ $2.26 2026-09-01 — French Glendon E. III · sold 4,098 @ $2.26 2026-09-01 — Radhakrishnan Srikanth · sold 2,121 @ $2.26 2026-09-01 — Radhakrishnan Srikanth · sold 2,643 @ $2.26 2026-09-01 — Radhakrishnan Srikanth · sold 3,618 @ $2.26 2026-09-01 — Radhakrishnan Srikanth · sold 5,863 @ $2.26
2026-09-012026-09-01

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Lehman David Aaron General Counsel
Rose Geoffrey Beran Chief Commercial Officer
Radhakrishnan Srikanth Chief Science & Techn. Officer
French Glendon E. III President and CEO, Director
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $LUNG is the reading of them — and for this company, that is what the list below says it is, no more.

  • Transaction timelineThe [{'transaction_date': '2026-09-01', 'insider_name': 'Lehman David Aaron', 'insider_title': 'General Counsel', 'transaction_type': 'Open-market sell', 'shares': 2224.0, 'price': 2.26, 'value': 5026.24, 'is_buy': False}, {'transaction_date': '2026-09-01', 'insider_name': 'Lehman David Aaron', 'insider_title': 'General Counsel', 'transaction_type': 'Open-market sell', 'shares': 3476.0, 'price': 2.26, 'value': 7855.76, 'is_buy': False}, {'transaction_date': '2026-09-01', 'insider_name': 'Lehman David Aaron', 'insider_title': 'General Counsel', 'transaction_type': 'Open-market sell', 'shares': 3807.0, 'price': 2.26, 'value': 8603.82, 'is_buy': False}, {'transaction_date': '2026-09-01', 'insider_name': 'Lehman David Aaron', 'insider_title': 'General Counsel', 'transaction_type': 'Open-market sell', 'shares': 4827.0, 'price': 2.26, 'value': 10909.02, 'is_buy': False}, {'transaction_date': '2026-09-01', 'insider_name': 'Rose Geoffrey Beran', 'insider_title': 'Chief Commercial Officer', 'transaction_type': 'Open-market sell', 'shares': 1530.0, 'price': 2.26, 'value': 3457.8, 'is_buy': False}, {'transaction_date': '2026-09-01', 'insider_name': 'Rose Geoffrey Beran', 'insider_title': 'Chief Commercial Officer', 'transaction_type': 'Open-market sell', 'shares': 1746.0, 'price': 2.26, 'value': 3945.96, 'is_buy': False}, {'transaction_date': '2026-09-01', 'insider_name': 'Rose Geoffrey Beran', 'insider_title': 'Chief Commercial Officer', 'transaction_type': 'Open-market sell', 'shares': 2213.0, 'price': 2.26, 'value': 5001.38, 'is_buy': False}, {'transaction_date': '2026-09-01', 'insider_name': 'Rose Geoffrey Beran', 'insider_title': 'Chief Commercial Officer', 'transaction_type': 'Open-market sell', 'shares': 2390.0, 'price': 2.26, 'value': 5401.4, 'is_buy': False}, {'transaction_date': '2026-09-01', 'insider_name': 'French Glendon E. III', 'insider_title': 'President and CEO, Director', 'transaction_type': 'Open-market sell', 'shares': 37784.0, 'price': 2.26, 'value': 85391.84, 'is_buy': False}, {'transaction_date': '2026-09-01', 'insider_name': 'French Glendon E. III', 'insider_title': 'President and CEO, Director', 'transaction_type': 'Open-market sell', 'shares': 4098.0, 'price': 2.26, 'value': 9261.48, 'is_buy': False}, {'transaction_date': '2026-09-01', 'insider_name': 'Radhakrishnan Srikanth', 'insider_title': 'Chief Science & Techn. Officer', 'transaction_type': 'Open-market sell', 'shares': 2121.0, 'price': 2.26, 'value': 4793.46, 'is_buy': False}, {'transaction_date': '2026-09-01', 'insider_name': 'Radhakrishnan Srikanth', 'insider_title': 'Chief Science & Techn. Officer', 'transaction_type': 'Open-market sell', 'shares': 2643.0, 'price': 2.26, 'value': 5973.18, 'is_buy': False}, {'transaction_date': '2026-09-01', 'insider_name': 'Radhakrishnan Srikanth', 'insider_title': 'Chief Science & Techn. Officer', 'transaction_type': 'Open-market sell', 'shares': 3618.0, 'price': 2.26, 'value': 8176.68, 'is_buy': False}, {'transaction_date': '2026-09-01', 'insider_name': 'Radhakrishnan Srikanth', 'insider_title': 'Chief Science & Techn. Officer', 'transaction_type': 'Open-market sell', 'shares': 5863.0, 'price': 2.26, 'value': 13250.38, 'is_buy': False}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for LUNG today: no reported open-market purchases in this window, so there is no insider cost basis to compute; no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.